Network pharmacology and in vitro experiments-based strategy to investigate the mechanisms of KangXianYiAi formula for hepatitis B virus-related hepatocellular carcinoma

Network pharmacology and in vitro experiments-based strategy to investigate the mechanisms of KangXianYiAi formula for hepatitis B virus-related hepatocellular carcinoma

The Chinese traditional medicine KangXianYiAi formula (KXYA) is used to treat hepatic disease in the clinic. Here we aim to confirm the therapeutic effects and explore the pharmacological mechanisms of KXYA on hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). We first collected and ana...

Full description

Bibliographic Details
Main Authors: Xu Cao, Hening Chen, Zhiguo Li, Xiaoke Li, Xianzhao Yang, Qiushuo Jin, Yijun Liang, Jiaxin Zhang, Meiyue Zhou, Ningyi Zhang, Guang Chen, Hongbo Du, Xiaobin Zao, Yong’an Ye
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Pharmacology
Subjects:
traditional Chinese medicine
HBV-related hepatocellular carcinoma
network pharmacological
bioinformatics
KangXianYiAi formula
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.985084/full

Similar Items

Similar Items